[ad_1]
Wading in for bargains right now is not the way to go, says Goldman Sachs’ tactical strategist Scott Rubner, who offers seasonal caution.
[ad_2]
Source link
FDA approves Eli Lilly’s weight loss drug Zepbound for sleep apnea
An Eli Lilly & Co. Zepbound injection pen arranged in the Brooklyn borough of New York, US, on Thursday, March...